212 related articles for article (PubMed ID: 18319322)
21. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
22. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
23. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
24. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
Liu YY; Zhang X; Ringel MD; Jhiang SM
Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
[TBL] [Abstract][Full Text] [Related]
25. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
[TBL] [Abstract][Full Text] [Related]
26. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.
Dufourny B; Alblas J; van Teeffelen HA; van Schaik FM; van der Burg B; Steenbergh PH; Sussenbach JS
J Biol Chem; 1997 Dec; 272(49):31163-71. PubMed ID: 9388270
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
28. Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.
Liu Z; Xing M
PLoS One; 2012; 7(2):e31729. PubMed ID: 22359623
[TBL] [Abstract][Full Text] [Related]
29. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
Elumalai P; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
31. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
[TBL] [Abstract][Full Text] [Related]
32. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
33. Effects of all-trans retinoic acid on sodium/iodide symporter and CCAAT/enhancer-binding protein-homologous protein under condition of endoplasmic reticulum stress in FRTL5 thyroid cells.
Lee SJ; Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ
Horm Metab Res; 2011 May; 43(5):331-6. PubMed ID: 21225541
[TBL] [Abstract][Full Text] [Related]
34. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines.
Sponziello M; Scipioni A; Durante C; Verrienti A; Maranghi M; Giacomelli L; Ferretti E; Celano M; Filetti S; Russo D
J Endocrinol Invest; 2010 Jan; 33(1):2-6. PubMed ID: 19794300
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
Spitzweg C; Scholz IV; Bergert ER; Tindall DJ; Young CY; Göke B; Morris JC
Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
[TBL] [Abstract][Full Text] [Related]
36. Unliganded estrogen receptor-alpha activates transcription of the mammary gland Na+/I- symporter gene.
Alotaibi H; Yaman EC; Demirpençe E; Tazebay UH
Biochem Biophys Res Commun; 2006 Jul; 345(4):1487-96. PubMed ID: 16730657
[TBL] [Abstract][Full Text] [Related]
37. KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.
Beyer S; Lakshmanan A; Liu YY; Zhang X; Wapnir I; Smolenski A; Jhiang S
Endocrinology; 2011 Mar; 152(3):782-92. PubMed ID: 21209020
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
39. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
40. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]